Submitted by drupal on Sat, 10/27/2012 - 4:21pm NCT00916617 Bapineuzumab United States Monday, June 1, 2009 – Monday, August 6, 2012 80 Phase 2 Alzheimer's Disease Janssen Pfizer Comments No Available Comments Make a Comment To make a comment you must login or register.
Submitted by drupal on
Submitted by drupal on
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.